Lignan-rich beans, nuts, and various seeds are the main protective food with antioxidative and hormones modulating activity. However, although the role of lignans in mediating hormone-dependent cancers, and cardiovascular disease is well characterized, the function of lignans in anti-arthritic activity and its actual mechanisms remain unknown. A set of three new lignan derivatives named (-)-nortrachelogenin, trachelogenin, and matairesinol were extracted from Loranthus parasiticus. After the establishment of collagen-induced arthritis (CIA) model by intradermal injection of collagen, rats were treated with the mixed three new lignan derivatives ((-)-nortrachelogenin: 37%; trachelogenin: 27%; matairesinol: 25.7%) at a concentration of 50 mg/kg and 100 mg/kg, or methotrexate of 0.3 mg/kg. The mixed lignan derivatives significantly attenuated the immune responses in the joints of CIA rats, resulting in decreased levels of pro-inflammatory cytokine (IL-6, TNF-α) and boosted free androgen in serum compared to the CIA model. The results of molecular docking via the AutoDock Vina showed that lignan derivative (-)-nortrachelogenin is the most effective compound for binding to SHBG, then leading to inhibiting the activity of NFκB in LPS-stimulated macrophages. In this study, (-)-nortrachelogenin was identified as the previously unrecognized anti-inflammatory activity of natural lignan new derivative, and its molecular mechanism is related to the regulating NFκB/SHBG pathway. Our findings suggest further application of sex hormone-like compounds in treating rheumatoid arthritis and potential clinical applications of (-)-nortrachelogenin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.